CG Oncology Inc header image

CG Oncology Inc

CGON

Equity

ISIN null / Valor 131996952

NASDAQ (2026-09-04)

USD 74.67+0.46%

CG Oncology Inc
UMushroom community rating:

5.00 1 votes No rating yet

NegativeNeutralPositive

About company

CG Oncology Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of oncolytic immunotherapies for bladder cancer. The company's primary investigational drug, cretostimogene, is designed to treat BCG-unresponsive, Non-Muscle Invasive Bladder Cancer (NMIBC). Although not yet approved by any regulatory agency, cretostimogene has demonstrated clinical benefits and has been generally well-tolerated in clinical trials, both as a monotherapy and in combination with other treatments. CG Oncology aims to provide innovative therapeutic options that enhance the quality of life for patients with urologic cancers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

141%1Y

%3Y

%5Y

Performance

55.3%1Y

63.1%3Y

63.1%5Y

Volatility

6619 M

Market cap (USD)

282,523

Daily traded volume (Shares)

29.6 / 27.85

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

1 votes

Performance:

3.00

Innovation:

3.00

Society:

3.00

Nature:

4.00

Damien Tan

Malaysia, 18 May 2026

E

EQUITIES OF THE SAME SECTOR

Essity AB

Essity AB Valor: 36851944

Annual Return

-50%0%+50%

Risk level

110

-0.33%SEK 272.20

Lifco Ab

Lifco Ab Valor: 111355378

Annual Return

-50%0%+50%

Risk level

110

-0.38%SEK 314.20

Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB Valor: 2676862

Annual Return

-50%0%+50%

Risk level

110

-1.13%SEK 454.80

Baxter International Inc

Baxter International Inc Valor: 911702

Annual Return

-50%0%+50%

Risk level

110

1.02%USD 25.83

Vitrolife AB

Vitrolife AB Valor: 41707777

Annual Return

-50%0%+50%

Risk level

110

-1.50%SEK 95.00

Elekta AB

Elekta AB Valor: 613625

Annual Return

-50%0%+50%

Risk level

110

-1.32%SEK 52.30

Camurus AB

Camurus AB Valor: 30510553

Annual Return

-50%0%+50%

Risk level

110

-2.17%SEK 587.00

Arjo AB

Arjo AB Valor: 39115843

Annual Return

-50%0%+50%

Risk level

110

-0.28%SEK 28.70

Biogaia AB

Biogaia AB Valor: 118922125

Annual Return

-50%0%+50%

Risk level

110

1.70%SEK 113.40

International Flavors & Fragrances Inc

International Flavors & Fragrances Inc Valor: 941876

Annual Return

-50%0%+50%

Risk level

110

-0.13%USD 86.35

SIX

FactSet

Clearbit

Logos provided by Clearbit